Clinical TrialsSearch results
Number of results: 66730
Not yet recruiting
- A randomized, double-blind, dose-ranging, placebo-controlled study to evaluate the efficacy and safety of PLN-74809 (bexotegrast) for the treatment of idiopathic pulmonary fibrosis
- idiopathic pulmonary fibrosis
- Kanmuri Kazuhiro
- 2024-05-07
Not yet recruiting
- A study of treatment of peripheral neuropathy with MSC-CM
- Peripheral neuropathy
- Kimura Shin
- 2024-05-07
Not yet recruiting
- Adjuvant therapy in pathological stage IA2-IIA EGFR-mutated NSCLC: a multicenter prospective observational study
- non-small cell lung cancer(non-squamous cell cancer)
- National Cancer Center
- 2024-05-07
Not yet recruiting
- Assessment of the educational effectiveness of a video-sharing system for remote endoscopists
- Pancreato-biliary disease, infectious colitis,Inflammatory bowel disease including disease to be differentiated
- Asahikawa Medical University
- 2024-05-07
Not yet recruiting
- Drug Use-Results Survey of PIASKY for Injection 340mg (All-Patient Surveillance) -Paroxysmal nocturnal hemoglobinuria-
- Paroxysmal nocturnal hemoglobinuria
- Chugai Pharmaceutical Co. Ltd.
- 2024-05-07
Not yet recruiting
- Multicenter retrospective study of the Efficacy of Adjuvant Immunotherapy after Radical therapy (Surgery or Radiotherapy) for Urothelial Carcinoma (Michinoku Study 1015)
- Bladder cancer
- Hirosaki University
- 2024-05-07
Not yet recruiting
- Randomized phase III trial in MMR deficient endometrial cancer patients comparing chemotherapy alone versus Dostarlimab in first line advanced/metastatic setting: DOMENICA STUDY
- endometrial adenocarcinoma
- Hasegawa Kosei
- 2024-05-07
Not yet recruiting
- Verification of the effect of test foods on the intestinal environment
- non-handicapped person
- Fuji Nihon Seito Corporation
- 2024-05-07
Not yet recruiting
- Verification of the effects of long-term intake of test food on glucose metabolism
- Healthy adults
- Miura Clinic, Medical Corporation Kanonkai
- 2024-05-07
Recruiting
- [M23-721] Study to Evaluate Adverse Events, Optimal Dose, and Change in Disease Activity, with Livmoniplimab in Combination with Budigalimab Plus Chemotherapy Versus IV Infused Pembrolizumab Plus Chemotherapy in Adult Participants with Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
- Non-Small Cell Lung Cancer
- Chika Yamagishi
- 2024-05-07